Vesna Spasojević-Kalimanovska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vesna Spasojević-Kalimanovska has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Jelena Kotur-Stevuljević
Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia
11 shared publications - Jelena Vekic
Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, Belgrade, Serbia
9 shared publications - Nataša Bogavac-Stanojević
Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
8 shared publications - Aleksandra Zeljkovic
Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia
6 shared publications - Ana Ninić
Department for Medical Biochemistry, University of Belgrade, Faculty of Pharmacy, Belgrade, Serbia
6 shared publications - Aleksandra Stefanović
University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade
5 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Arhiv za farmaciju
- Vol. 75 (1) , 84-100
Association between systemic inflammation and lipid metabolism in the development of preeclampsia
Preeclampsia (PE) is a pregnancy complication marked by hypertension (≥ 140/90 mmHg) and proteinuria (≥ 300 mg/24 h), with an unclear pathogenesis involving inflammation and dyslipidemia. This study aimed to longitudinally examine changes in lipid status parameters and inflammatory markers in pregnant women at high risk for PE and those who developed PE. Among 91 women, 20 developed PE (PE group), and 71 were high-risk (HR group). Both groups were monitored at four points: T1-first, T2-, T3-third trimester, and T4-pre-delivery. Lipid markers (triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, apolipoproteins A-I and B100) and inflammatory markers (high-sensitivity C-reactive protein (hsCRP), resistin, serum amyloid A (SAA), and macrophage chemotactic protein-1 (MCP-1)) were assessed. Results showed significantly higher TG, resistin, and MCP-1 concentrations in the PE group compared to the HR group at T1 (p < 0.05, p < 0.01, p < 0.01, respectively). During pregnancy, both groups exhibited increases in TG, TC, LDL-C, SAA, and MCP-1 (p < 0.001), while HDL-C and resistin increased only in the HR group (p < 0.001). PE development is associated with atherogenic lipid changes, characterized by hypertriglyceridemia and no increase in HDL-C, with elevated SAA potentially diminishing HDL's protective role.
- 1 January 2025
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Arhiv za farmaciju
- Vol. 75 (1) , 84-100
Open AccessAssociation between systemic inflammation and lipid metabolism in the development of preeclampsia
Preeclampsia (PE) is a pregnancy complication marked by hypertension (≥ 140/90 mmHg) and proteinuria (≥ 300 mg/24 h), with an unclear pathogenesis involving inflammation and dyslipidemia. This study aimed to longitudinally examine changes in lipid status parameters and inflammatory markers in pregnant women at high risk for PE and those who developed PE. Among 91 women, 20 developed PE (PE group), and 71 were high-risk (HR group). Both groups were monitored at four points: T1-first, T2-, T3-third trimester, and T4-pre-delivery. Lipid markers (triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, apolipoproteins A-I and B100) and inflammatory markers (high-sensitivity C-reactive protein (hsCRP), resistin, serum amyloid A (SAA), and macrophage chemotactic protein-1 (MCP-1)) were assessed. Results showed significantly higher TG, resistin, and MCP-1 concentrations in the PE group compared to the HR group at T1 (p < 0.05, p < 0.01, p < 0.01, respectively). During pregnancy, both groups exhibited increases in TG, TC, LDL-C, SAA, and MCP-1 (p < 0.001), while HDL-C and resistin increased only in the HR group (p < 0.001). PE development is associated with atherogenic lipid changes, characterized by hypertriglyceridemia and no increase in HDL-C, with elevated SAA potentially diminishing HDL's protective role.
- Open Access
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 43 (3) , 413-423
The influence of various sample storage conditions and sample bacterial contamination on concentrations of routine biochemical parameters
Background: The pre-analytical (PA) phase is the most vulnerable phase of the laboratory testing procedure, with critical procedures-collection, handling, sample transport, and time and temperature of sample storage. This study aimed to examine the stability of basic biochemical parameters depending on the samples' storage conditions and the number of freeze-thaw cycles (FTCs). In parallel, the presence of sample bacterial contamination during routine laboratory work was examined. Methods: Two plasma pools (ethylenediaminetetraacetic acid (EDTA), and sodium-fluoride/potassium oxalate plasma (NaF)) were stored at +4 ˚C/-20 ˚C. Total chole - sterol (TC), glucose, triglycerides (TG), urea, and albumin concentrations were measured using BioSystems reagents (cholesterol oxidase/peroxidase, glucose oxidase/per - oxidase, glycerol phosphate oxidase/peroxidase, urease/ salicylate, and bromcresol green method, respectively) on Ilab 300+. Sample bacterial contamination was determined by 16S rRNA sequence analysis. The expe - riment encompassed a 5 day-period: Day 1-fresh sample, Day 2-1st FTC, Day 3-2nd FTC, Day 4-3rd FTC, Day 5-4th FTC. The appearance of bacteria in two consecutive samples was the experiment's endpoint. Results: During 4 FTCs, there were no changes in plasma urea concentrations. Glucose was stable in EDTA +4 ˚C and NaF -20 ˚C until the 3rd FTC (P=0.008, P=0.042, respectively). TG concentrations changed significantly in the EDTA -20 ˚C sample after 1st and 4th FTCs (P=0.022, P=0.010, respectively). In NaF samples, no bacterial contamination was observed during 4 FTCs. Conclusion: Urea and glucose concentrations were robust. Changes in lipid concentrations after FTCs follow complex patterns. Bacterial growth was not observed in NaF plasma samples. This can promote NaF use in analytical procedures in which bacterial contamination affects the quality of analysis.
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 43 (3) , 413-423
Open AccessThe influence of various sample storage conditions and sample bacterial contamination on concentrations of routine biochemical parameters
Background: The pre-analytical (PA) phase is the most vulnerable phase of the laboratory testing procedure, with critical procedures-collection, handling, sample transport, and time and temperature of sample storage. This study aimed to examine the stability of basic biochemical parameters depending on the samples' storage conditions and the number of freeze-thaw cycles (FTCs). In parallel, the presence of sample bacterial contamination during routine laboratory work was examined. Methods: Two plasma pools (ethylenediaminetetraacetic acid (EDTA), and sodium-fluoride/potassium oxalate plasma (NaF)) were stored at +4 ˚C/-20 ˚C. Total chole - sterol (TC), glucose, triglycerides (TG), urea, and albumin concentrations were measured using BioSystems reagents (cholesterol oxidase/peroxidase, glucose oxidase/per - oxidase, glycerol phosphate oxidase/peroxidase, urease/ salicylate, and bromcresol green method, respectively) on Ilab 300+. Sample bacterial contamination was determined by 16S rRNA sequence analysis. The expe - riment encompassed a 5 day-period: Day 1-fresh sample, Day 2-1st FTC, Day 3-2nd FTC, Day 4-3rd FTC, Day 5-4th FTC. The appearance of bacteria in two consecutive samples was the experiment's endpoint. Results: During 4 FTCs, there were no changes in plasma urea concentrations. Glucose was stable in EDTA +4 ˚C and NaF -20 ˚C until the 3rd FTC (P=0.008, P=0.042, respectively). TG concentrations changed significantly in the EDTA -20 ˚C sample after 1st and 4th FTCs (P=0.022, P=0.010, respectively). In NaF samples, no bacterial contamination was observed during 4 FTCs. Conclusion: Urea and glucose concentrations were robust. Changes in lipid concentrations after FTCs follow complex patterns. Bacterial growth was not observed in NaF plasma samples. This can promote NaF use in analytical procedures in which bacterial contamination affects the quality of analysis.
- Open Access
- 29 July 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 41 (3) , 282-289
Downregulation of mapk/mak/mrk overlapping kinase 1 in peripheral blood mononuclear cells of pediatric patients with type 1 diabetes mellitus
Background: Type 1 diabetes mellitus (T1DM) is one of the most common endocrine diseases in children. T-cell autoreactivity toward b-cells is controlled by significant changes in metabolism of T cells. Mammalian target of rapamycin (mTOR) is an important intracellular regulator of metabolism and cell growth. MAPK/MAK/MRK overlapping kinase 1 (MOK1) is one of the less known regulators of mTOR. We sought to investigate if MOK1 and mTOR mRNA levels in peripheral blood mononuclear cells (PBMCs) of T1DM pediatric patients are different compared to healthy subjects. Methods: This study included 172 adolescents with T1DM and 36 healthy adolescent volunteers designated for control group (CG). MOK1 and mTOR mRNA levels were determined in PBMCs by qPCR. Results: T1DM patients have significant downregulation of MOK1 mRNA levels in PBMCs compared CG (P=0.018), while there was no significant difference in mTOR mRNA levels (P=0.891). Furthermore, in T1DM patients, MOK1 significantly correlated with age, triglycerides and mTOR, while mTOR correlated significantly with BMI and systolic blood pressure. Overweight T1DM subjects had significantly lower MOK1 (P=0.034) and mTOR (P=0.017) mRNA levels, together with significantly higher levels of systolic blood pressure (P<0.001), total cholesterol (P=0.001), LDL-cholesterol (P=0.001) and CRP (P<0.001). Multi - variate analysis showed that MOK1 was independently negatively associated with T1DM when adjusted for sex, age, HDL-C and CRP (OR=0.417 (95%CI: 0.175-0.997), p=0.049). Conclusions: Our study demonstrated for the first time that T1DM is associated with MOK1 downregulation. In addition, downregulation of both mTOR and MOK1 gene expressions was associated with cardiovascular risk factors in overweight T1DM patients.
- 29 July 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 41 (3) , 282-289
Open AccessDownregulation of mapk/mak/mrk overlapping kinase 1 in peripheral blood mononuclear cells of pediatric patients with type 1 diabetes mellitus
Background: Type 1 diabetes mellitus (T1DM) is one of the most common endocrine diseases in children. T-cell autoreactivity toward b-cells is controlled by significant changes in metabolism of T cells. Mammalian target of rapamycin (mTOR) is an important intracellular regulator of metabolism and cell growth. MAPK/MAK/MRK overlapping kinase 1 (MOK1) is one of the less known regulators of mTOR. We sought to investigate if MOK1 and mTOR mRNA levels in peripheral blood mononuclear cells (PBMCs) of T1DM pediatric patients are different compared to healthy subjects. Methods: This study included 172 adolescents with T1DM and 36 healthy adolescent volunteers designated for control group (CG). MOK1 and mTOR mRNA levels were determined in PBMCs by qPCR. Results: T1DM patients have significant downregulation of MOK1 mRNA levels in PBMCs compared CG (P=0.018), while there was no significant difference in mTOR mRNA levels (P=0.891). Furthermore, in T1DM patients, MOK1 significantly correlated with age, triglycerides and mTOR, while mTOR correlated significantly with BMI and systolic blood pressure. Overweight T1DM subjects had significantly lower MOK1 (P=0.034) and mTOR (P=0.017) mRNA levels, together with significantly higher levels of systolic blood pressure (P<0.001), total cholesterol (P=0.001), LDL-cholesterol (P=0.001) and CRP (P<0.001). Multi - variate analysis showed that MOK1 was independently negatively associated with T1DM when adjusted for sex, age, HDL-C and CRP (OR=0.417 (95%CI: 0.175-0.997), p=0.049). Conclusions: Our study demonstrated for the first time that T1DM is associated with MOK1 downregulation. In addition, downregulation of both mTOR and MOK1 gene expressions was associated with cardiovascular risk factors in overweight T1DM patients.
- Open Access
- 1 January 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Arhiv za farmaciju
- Vol. 72 (2) , 260-273
Biomarkers of vitamin D status in healthy adults: Associations with serum lipid parameters: A pilot study
Vitamin D deficiency is among important healthcare challenges today. Traditionally, vitamin D status is assessed through determination of 25-hydroxy metabolite (25(OH)D), but novel data point to 24,25(OH)2D and 25(OH)D/24,25(OH)2D ratio (VDMR) as promising biomarkers. It is widely accepted that the biological role of vitamin D exceeds its well-known contribution to bone turnover. However, its effects on overall energy metabolism and lipid status alterations are not completely understood. In this study, we analyzed the relationship of vitamin D status assessed as concentrations of 25(OH)D3 and 24,25(OH)2D3 determined by liquid chromatography-tandem mass spectrometry, as well as VDMR with advanced lipid status parameters. Vitamin D status biomarkers, routine parameters of lipid status and size and distribution of lipoprotein subclasses were determined in 89 healthy adults (35 with adequate vitamin D status and 54 with vitamin D deficiency). Our results indicated a preponderance of proatherogenic small, dense LDL particles (sdLDL) in vitamin D deficient subjects. Both 25(OH)D and 24,25(OH)2D were associated with a relative proportion of sdLDL (B: -0.410; SE: 0.154; P=0.010; and B: -2.041; SE: 0.969; P=0.039, respectively). Positive correlation was found for VDMR and relative proportion of HDL 3a particles (r=0.251; P=0.024). VDMR value was decreased in subjects with vitamin D deficiency (P=0.001), thus implying its usefulness as a biomarker. A thorough investigation of novel vitamin D biomarkers and advanced lipid status parameters can be useful in the estimation of individual risk for the development of cardiometabolic alterations.
- 1 January 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Arhiv za farmaciju
- Vol. 72 (2) , 260-273
Open AccessBiomarkers of vitamin D status in healthy adults: Associations with serum lipid parameters: A pilot study
Vitamin D deficiency is among important healthcare challenges today. Traditionally, vitamin D status is assessed through determination of 25-hydroxy metabolite (25(OH)D), but novel data point to 24,25(OH)2D and 25(OH)D/24,25(OH)2D ratio (VDMR) as promising biomarkers. It is widely accepted that the biological role of vitamin D exceeds its well-known contribution to bone turnover. However, its effects on overall energy metabolism and lipid status alterations are not completely understood. In this study, we analyzed the relationship of vitamin D status assessed as concentrations of 25(OH)D3 and 24,25(OH)2D3 determined by liquid chromatography-tandem mass spectrometry, as well as VDMR with advanced lipid status parameters. Vitamin D status biomarkers, routine parameters of lipid status and size and distribution of lipoprotein subclasses were determined in 89 healthy adults (35 with adequate vitamin D status and 54 with vitamin D deficiency). Our results indicated a preponderance of proatherogenic small, dense LDL particles (sdLDL) in vitamin D deficient subjects. Both 25(OH)D and 24,25(OH)2D were associated with a relative proportion of sdLDL (B: -0.410; SE: 0.154; P=0.010; and B: -2.041; SE: 0.969; P=0.039, respectively). Positive correlation was found for VDMR and relative proportion of HDL 3a particles (r=0.251; P=0.024). VDMR value was decreased in subjects with vitamin D deficiency (P=0.001), thus implying its usefulness as a biomarker. A thorough investigation of novel vitamin D biomarkers and advanced lipid status parameters can be useful in the estimation of individual risk for the development of cardiometabolic alterations.
- Open Access
- 1 January 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Arhiv za farmaciju
- Vol. 72 (2) , 247-259
Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy?
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin family that provides useful prognostic information and facilitates diagnostics of cardiovascular diseases. This study investigated the effect of statin therapy on PTX3 and hsCRP concentrations and whether statins acted synergistically with PTX3 and hsCRP concentrations in lowering LDL-C. The study group consisted of 90 patients undergoing coronary angiography. The results showed that statins reduced PTX3 concentrations (p=0.031). PTX3 and hsCRP levels were significantly different between subclinical and severe stenosis groups (p=0.011 and p=0.009, respectively). Statin therapy was significantly associated with lower PTX3 and LDL-C levels in multiple logistic analyses. The probability that statin therapy would achieve target LDL-C values was highest in patients with low PTX3 values (OR=3.683, p=0.040), while multiplicative interaction was 23.3. The effect of statins on PTX3 reduction was higher than on hsCRP. It can be suggested that statin therapy was more successful in patients with low PTX3 values.
- 1 January 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Arhiv za farmaciju
- Vol. 72 (2) , 247-259
Open AccessDoes Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy?
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin family that provides useful prognostic information and facilitates diagnostics of cardiovascular diseases. This study investigated the effect of statin therapy on PTX3 and hsCRP concentrations and whether statins acted synergistically with PTX3 and hsCRP concentrations in lowering LDL-C. The study group consisted of 90 patients undergoing coronary angiography. The results showed that statins reduced PTX3 concentrations (p=0.031). PTX3 and hsCRP levels were significantly different between subclinical and severe stenosis groups (p=0.011 and p=0.009, respectively). Statin therapy was significantly associated with lower PTX3 and LDL-C levels in multiple logistic analyses. The probability that statin therapy would achieve target LDL-C values was highest in patients with low PTX3 values (OR=3.683, p=0.040), while multiplicative interaction was 23.3. The effect of statins on PTX3 reduction was higher than on hsCRP. It can be suggested that statin therapy was more successful in patients with low PTX3 values.
- Open Access
- 26 February 2021
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (1) , 61-71
Transforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 Diabetes Mellitus
Objective: Type 1 diabetes (T1D) mellitus is one of the most frequent autoimmune diseases in childhood. Chronic complications are the main causes of cardiovascular morbidity and mortality in T1D. Although interactions between advanced glycation end products (AGE) and their receptors (RAGE) and transforming growth factor-beta 1 (TGF-beta 1) are implicated in development and progression of diabetic microand macro-vascular complications, they also have important roles in immune system regulation. Methods: Blood samples were obtained from 156 adolescents with T1D and 80 apparently healthy controls. T1D patients diagnosed with any other autoimmune disease and receiving any kind of drugs except insulin therapy were excluded from this study. Exclusion criteria for controls were positive family history of T1D and drugs/supplements application. TGF-beta 1 and transmembrane full-length RAGE (flRAGE) messenger ribonucleic acid (mRNA) levels in peripheral blood mononuclear cells (PBMC) were obtained by quantitative polymerase chain reaction (qPCR) method. Circulating levels of biochemical markers, TGF-beta 1 and soluble RAGE (sRAGE) levels were also determined. Results: TGF-beta 1 and flRAGE mRNA levels were significantly higher in controls compared to patients (p<0.001, for both). However, TGF-beta 1 and sRAGE levels were higher in patients than controls (p<0.001, for both). There were significant independent associations of all mRNA and protein levels with T1D. TGF-beta 1 mRNA was the only marker independently negatively associated with urinary albumin excretion rate in T1D adolescents (p=0.005). Conclusion: Our results indicated gene expression downregulation of TGF-beta 1 and flRAGE in PBMC of T1D adolescents. TGF-beta 1 mRNA downregulation may be useful for predicting early elevation of urinary albumin excretion rate.
- 26 February 2021
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (1) , 61-71
Open AccessTransforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 Diabetes Mellitus
Objective: Type 1 diabetes (T1D) mellitus is one of the most frequent autoimmune diseases in childhood. Chronic complications are the main causes of cardiovascular morbidity and mortality in T1D. Although interactions between advanced glycation end products (AGE) and their receptors (RAGE) and transforming growth factor-beta 1 (TGF-beta 1) are implicated in development and progression of diabetic microand macro-vascular complications, they also have important roles in immune system regulation. Methods: Blood samples were obtained from 156 adolescents with T1D and 80 apparently healthy controls. T1D patients diagnosed with any other autoimmune disease and receiving any kind of drugs except insulin therapy were excluded from this study. Exclusion criteria for controls were positive family history of T1D and drugs/supplements application. TGF-beta 1 and transmembrane full-length RAGE (flRAGE) messenger ribonucleic acid (mRNA) levels in peripheral blood mononuclear cells (PBMC) were obtained by quantitative polymerase chain reaction (qPCR) method. Circulating levels of biochemical markers, TGF-beta 1 and soluble RAGE (sRAGE) levels were also determined. Results: TGF-beta 1 and flRAGE mRNA levels were significantly higher in controls compared to patients (p<0.001, for both). However, TGF-beta 1 and sRAGE levels were higher in patients than controls (p<0.001, for both). There were significant independent associations of all mRNA and protein levels with T1D. TGF-beta 1 mRNA was the only marker independently negatively associated with urinary albumin excretion rate in T1D adolescents (p=0.005). Conclusion: Our results indicated gene expression downregulation of TGF-beta 1 and flRAGE in PBMC of T1D adolescents. TGF-beta 1 mRNA downregulation may be useful for predicting early elevation of urinary albumin excretion rate.
- 1 January 2021
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hrana i ishrana
- Vol. 62 (2) , 33
Corrigendum: Comparison of the antioxidative action of the two N-acetylcystein containing products: Propomucil® and Fluimucil® in a group of smokers who have seasonal coughing problems (2018, vol. 59, no. 1, pp. 33-41)
At every place in the article word Fluimucil is replaced by NAC (N-acetil-cysteine) as follows: 1. Article titles (English and Serbian version) from the Content, general article title (page 33) and article headers at the pages 33-41. 2. INTRODUCTION - Last sentence in the Introduction section (page 34). 3. MATERIAL AND METHOD - Second sentence in the first paragraph (page 34); Second column, third paragraph (page 34). 4. RESULTS - First column, second paragraph at the page 36; Figure 2 title (page 37); first column, first paragraph (page 37); subtitle (page 37); text second column, second paragraph (page 37); Table 3 header (page 38); first column first paragraph text below the table 3 (page 38); text below the subtitle: second column, second paragraph (page 38); text below Figure 3 (legend, page 38); Table 4 header (page 39). 5. CONCLUSION - page 40. The authors would like to apologise for any inconvenience caused.
- 1 January 2021
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hrana i ishrana
- Vol. 62 (2) , 33
Corrigendum: Comparison of the antioxidative action of the two N-acetylcystein containing products: Propomucil® and Fluimucil® in a group of smokers who have seasonal coughing problems (2018, vol. 59, no. 1, pp. 33-41)
At every place in the article word Fluimucil is replaced by NAC (N-acetil-cysteine) as follows: 1. Article titles (English and Serbian version) from the Content, general article title (page 33) and article headers at the pages 33-41. 2. INTRODUCTION - Last sentence in the Introduction section (page 34). 3. MATERIAL AND METHOD - Second sentence in the first paragraph (page 34); Second column, third paragraph (page 34). 4. RESULTS - First column, second paragraph at the page 36; Figure 2 title (page 37); first column, first paragraph (page 37); subtitle (page 37); text second column, second paragraph (page 37); Table 3 header (page 38); first column first paragraph text below the table 3 (page 38); text below the subtitle: second column, second paragraph (page 38); text below Figure 3 (legend, page 38); Table 4 header (page 39). 5. CONCLUSION - page 40. The authors would like to apologise for any inconvenience caused.
- 1 January 2021
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hrana i ishrana
- Vol. 62 (1) , 28-36
Antioxidant, anti-inflammatory, and anti-hyperlipidemic properties of the spelt grass juice
Spelt is a grain rich in bioactive compounds - different phytochemicals, so it is often mentioned in the context of being beneficial to human health. We aimed to investigate the antioxidant, anti-inflammatory, and anti-hyperlipidemic properties of the spelt grass juice. Twenty volunteers consumed a beverage once a day, by dissolving one dose in 200 ml of still water, for 2 months. All individuals were clinically and biochemically examined. The individual profiles of LDL and HDL particles were determined by polyacrylamide gradient gel electrophoresis, while the concentrations of non-cholesterol sterols were measured using the gas chromatography - flame ionization detector. High-sensitivity Creactive protein (hsCRP) was measured using the commercially available kit. Concentrations of oxidative stress status parameters were measured spectrophotometrically. Though no change was observed in lipid profile parameters, values of coronary risk (CRI) (p < 0.05) and the atherogenic indexes (AI) (p < 0.05) after the supplementation were lower compared with values before the dietary intervention. After analyzing the markers of cholesterol synthesis and absorption, we only noticed a significant increase in campesterol concentrations (p < 0.05). Moreover, we found a statistically significant reduction in hsCRP concentrations in subjects who underwent spelt juice supplementation (p < 0.001). A significant decrease in PAB (p < 0.001), AOPP (p < 0.05) and PON1 (p < 0.001) was recorded after supplementation. On the other side, TAS values and concentration of SH groups were significantly higher after the dietary intervention (p < 0.001, both). We suggested a possible beneficial effect of the spelt grass supplementation on the overall lipid profile, the prooxidant-antioxidant balance, and inflammatory parameters.
- 1 January 2021
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Hrana i ishrana
- Vol. 62 (1) , 28-36
Antioxidant, anti-inflammatory, and anti-hyperlipidemic properties of the spelt grass juice
Spelt is a grain rich in bioactive compounds - different phytochemicals, so it is often mentioned in the context of being beneficial to human health. We aimed to investigate the antioxidant, anti-inflammatory, and anti-hyperlipidemic properties of the spelt grass juice. Twenty volunteers consumed a beverage once a day, by dissolving one dose in 200 ml of still water, for 2 months. All individuals were clinically and biochemically examined. The individual profiles of LDL and HDL particles were determined by polyacrylamide gradient gel electrophoresis, while the concentrations of non-cholesterol sterols were measured using the gas chromatography - flame ionization detector. High-sensitivity Creactive protein (hsCRP) was measured using the commercially available kit. Concentrations of oxidative stress status parameters were measured spectrophotometrically. Though no change was observed in lipid profile parameters, values of coronary risk (CRI) (p < 0.05) and the atherogenic indexes (AI) (p < 0.05) after the supplementation were lower compared with values before the dietary intervention. After analyzing the markers of cholesterol synthesis and absorption, we only noticed a significant increase in campesterol concentrations (p < 0.05). Moreover, we found a statistically significant reduction in hsCRP concentrations in subjects who underwent spelt juice supplementation (p < 0.001). A significant decrease in PAB (p < 0.001), AOPP (p < 0.05) and PON1 (p < 0.001) was recorded after supplementation. On the other side, TAS values and concentration of SH groups were significantly higher after the dietary intervention (p < 0.001, both). We suggested a possible beneficial effect of the spelt grass supplementation on the overall lipid profile, the prooxidant-antioxidant balance, and inflammatory parameters.
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population
Different byproducts of oxidative stress do not always lead to the same conclusion regarding its relationship with cardiometabolic risk, since controversial results are reported so far. The aim of the current study was to examine prooxidant determinant ((prooxidant‐antioxidant balance (PAB)) and the marker of antioxidant defence capacity (total sulphydryl groups (tSHG)), as well as their ratio (PAB/tSHG) in relation to different cardiometabolic risk factors in the cohort of adult population. Additionally, we aimed to examine the joint effect of various cardiometabolic parameters on these markers, since to our knowledge, there are no studies that investigated that issue. A total of 292 participants underwent anthropometric measurements and venipuncture procedure for cardiometabolic risk factors assessment. Waist‐to‐height ratio (WHtR), body mass index, visceral adiposity index (VAI), and lipid accumulation product (LAP) were calculated. Principal component analysis (PCA) grouped various cardiometabolic risk parameters into different factors. This analysis was used in the subsequent binary logistic regression analysis to estimate the predictive potency of the factors towards the highest PAB and tSHG values. Our results show that triglycerides, VAI, and LAP were positively and high density lipoprotein cholesterol (HDL‐c) were negatively correlated with tSHG levels and vice versa with PAB/tSHG index, respectively. On the contrary, there were no independent correlations between each cardiometabolic risk factor and PAB. PCA revealed that obesity‐renal function‐related factor (i.e., higher WHtR, but lower urea and creatinine) predicts both high PAB (OR = 1.617, 95% CI (1.204‐2.171), P < 0.01) and low tSHG values (OR = 0.443, 95% CI (0.317‐0.618), P < 0.001), while obesity‐dyslipidemia‐related factor (i.e., lower HDL‐c and higher triglycerides, VAI, and LAP) predicts high tSHG values (OR = 2.433, 95% CI (1.660‐3.566), P < 0.001). In conclusion, unfavorable cardiometabolic profile was associated with higher tSHG values. Further studies are needed to examine whether increased antioxidative capacity might be regarded as a compensatory mechanism due to free radicals’ harmful effects.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessFactorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population
Different byproducts of oxidative stress do not always lead to the same conclusion regarding its relationship with cardiometabolic risk, since controversial results are reported so far. The aim of the current study was to examine prooxidant determinant ((prooxidant‐antioxidant balance (PAB)) and the marker of antioxidant defence capacity (total sulphydryl groups (tSHG)), as well as their ratio (PAB/tSHG) in relation to different cardiometabolic risk factors in the cohort of adult population. Additionally, we aimed to examine the joint effect of various cardiometabolic parameters on these markers, since to our knowledge, there are no studies that investigated that issue. A total of 292 participants underwent anthropometric measurements and venipuncture procedure for cardiometabolic risk factors assessment. Waist‐to‐height ratio (WHtR), body mass index, visceral adiposity index (VAI), and lipid accumulation product (LAP) were calculated. Principal component analysis (PCA) grouped various cardiometabolic risk parameters into different factors. This analysis was used in the subsequent binary logistic regression analysis to estimate the predictive potency of the factors towards the highest PAB and tSHG values. Our results show that triglycerides, VAI, and LAP were positively and high density lipoprotein cholesterol (HDL‐c) were negatively correlated with tSHG levels and vice versa with PAB/tSHG index, respectively. On the contrary, there were no independent correlations between each cardiometabolic risk factor and PAB. PCA revealed that obesity‐renal function‐related factor (i.e., higher WHtR, but lower urea and creatinine) predicts both high PAB (OR = 1.617, 95% CI (1.204‐2.171), P < 0.01) and low tSHG values (OR = 0.443, 95% CI (0.317‐0.618), P < 0.001), while obesity‐dyslipidemia‐related factor (i.e., lower HDL‐c and higher triglycerides, VAI, and LAP) predicts high tSHG values (OR = 2.433, 95% CI (1.660‐3.566), P < 0.001). In conclusion, unfavorable cardiometabolic profile was associated with higher tSHG values. Further studies are needed to examine whether increased antioxidative capacity might be regarded as a compensatory mechanism due to free radicals’ harmful effects.
- Open Access
- 1 January 2021
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 40 (1) , 41-48
Serum endocan levels in relation to traditional and non-traditional anthropometric indices in adult population
Background: Association between endocan and nontraditional anthropometric indices, as distinct cardiovascular disease risk factors, has not been examined in previous studies. Endocan is a novel inflammation biomarker with its higher levels involved in cardiometabolic diseases development. Taking into consideration that obesity is an independent risk factor for many cardiometabolic diseases, we aimed to explore the relationship between endocan levels and novel anthropometric indices i.e., body adiposity index (BAI), cardiometabolic index (CMI), a body shape index, body roundness index, conicity index, lipid accumulation product index and visceral adiposity index and traditional ones i.e., waist circumference, hip circumference, body mass index, waist-to-height ratio and waist-to-hip ratio in adult population. Methods: A total of 177 participants were included. Anthropometric indices and biochemical parametres were measured. Results: Univariate regression analysis demonstrated positive correlations of endocan and almost all anthropometric data. To explore independent associations of endocan and anthropometric parameters, the Model which fulfilled criteria for ordinal regression testing was created. Adjusted odds for BAI given in the Model (OR=1.120, 95% CI 1.036-1.212, P=0.004), demonstrated that a rise in BAI by 1 unit increased the probability of higher endocan concentration by 12%. As well, a rise in CMI for 1 unit, increased the probability for higher endocan levels for 2.6 times (OR=2.599, 95% CI 1.006-6.712, P=0.049). A total of 20.1% of variation in endocan levels could be explained by this Model. Conclusions: Non-traditional obesity indices, BAI and CMI independently correlated with higher serum endocan levels in adult population.
- 1 January 2021
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 40 (1) , 41-48
Open AccessSerum endocan levels in relation to traditional and non-traditional anthropometric indices in adult population
Background: Association between endocan and nontraditional anthropometric indices, as distinct cardiovascular disease risk factors, has not been examined in previous studies. Endocan is a novel inflammation biomarker with its higher levels involved in cardiometabolic diseases development. Taking into consideration that obesity is an independent risk factor for many cardiometabolic diseases, we aimed to explore the relationship between endocan levels and novel anthropometric indices i.e., body adiposity index (BAI), cardiometabolic index (CMI), a body shape index, body roundness index, conicity index, lipid accumulation product index and visceral adiposity index and traditional ones i.e., waist circumference, hip circumference, body mass index, waist-to-height ratio and waist-to-hip ratio in adult population. Methods: A total of 177 participants were included. Anthropometric indices and biochemical parametres were measured. Results: Univariate regression analysis demonstrated positive correlations of endocan and almost all anthropometric data. To explore independent associations of endocan and anthropometric parameters, the Model which fulfilled criteria for ordinal regression testing was created. Adjusted odds for BAI given in the Model (OR=1.120, 95% CI 1.036-1.212, P=0.004), demonstrated that a rise in BAI by 1 unit increased the probability of higher endocan concentration by 12%. As well, a rise in CMI for 1 unit, increased the probability for higher endocan levels for 2.6 times (OR=2.599, 95% CI 1.006-6.712, P=0.049). A total of 20.1% of variation in endocan levels could be explained by this Model. Conclusions: Non-traditional obesity indices, BAI and CMI independently correlated with higher serum endocan levels in adult population.